Supply problems and insurance complications have made it difficult for people to start — and stay on — Wegovy and similar medications that are transforming obesity treatment, according to doctors and patients around the country. They say getting the high-demand, injectable drugs requires persistence and a fair amount of luck.
People starting on Wegovy have to take injections of gradually increasing strength before they reach the so-called maintenance dose that they stay on.
Finding Wegovy can become a part-time job for patients, said Dr. Diana Thiara, medical director of the weight management clinic at the University of California, San Francisco. One of Fitch’s patients, Mike Bouboulis, has taken Saxenda, Mounjaro or Ozempic, a Novo diabetes drug with the same active ingredient as Wegovy, since around 2019. It became much harder for him to find the drugs in the past year, after their popularity exploded.“They all know what you’re calling for, and they all have the same answer: ‘I don’t know. We’ll see tomorrow,’” said the 35-year-old small business owner who lives outside Boston.
The federal Medicare program for people age 65 and older doesn’t cover obesity medicines, but some privately run Medicare Advantage or Medigap plans do, according to Novo. Coverage from Medicaid programs for people with low incomes varies.Doctors and patients say many insurers have stopped covering Ozempic and Mounjaro outside their approved use for diabetes. Some insurers and employers don’t pay for Wegovy.
“For me, it’s either they have coverage through insurance, or they’re not taking it,” she said. “No one can afford it.”Advertisement
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Supply problems and insurance issues make popular weight-loss drugs hard to getSupply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity.
続きを読む »
Supply problems and insurance issues make popular weight-loss drugs hard to getSupply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity.
続きを読む »
Injectable drugs help people lose weight – if they win supply, insurance battlesSupply problems and insurance complications have made it difficult for people to start — and stay on — medications that are transforming obesity treatment.
続きを読む »
Oil prices extend rally on China stimulus cheer, tight supply outlook By Investing.comOil prices extend rally on China stimulus cheer, tight supply outlook
続きを読む »
WTI surges to the fresh YTD high above the $90.10 mark amid tighter supply expectationsWestern Texas Intermediate (WTI), the US crude oil benchmark, is trading around $90.10 so far on Friday. WTI prices climb to the Year-To-Date (YTD) hi
続きを読む »